JO

Journal of Thoracic Oncology

Journal of Thoracic Oncology is the official journal of the International Association for the Study of Lung Cancer and the primary educational and informational publication for prevention, detection, diagnosis, and treatment of thoracic malignancies. It emphasizes a multidisciplinary approach and includes original research, reviews, and opinion pieces for clinicians and research scientists with an interest in thoracic oncology.

Looking to publish in Journal of Thoracic Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology, Respiratory System
Impact Factor 20.8
Quartile Q1
Open Access Type Hybrid
ISSN 1556-0864
eISSN 1556-1380
Invitation Only No
Cost Range Hybrid journal with open access content; publication cost not specified

Submission Instructions

Journal of Thoracic Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Original Articles must include a structured abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Original Articles must contain 4,000 words of text. The manuscript must be organized under the main headings Introduction, Materials and Methods, Results, and Discussion. The manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in writing, a Declaration of Generative AI and AI-assisted technologies in the writing process before the references.
References Original Articles may include up to 50 references. References must be cited in the text as consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Original Articles may include up to 6 tables and/or figures. Each illustration must be submitted as a separate file. Tables must be submitted as editable text rather than images.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be limited to 250 words. Abstract must be structured. Abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Review Articles should be no longer than 4000 words. Manuscript must be organized under the four main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in writing, a 'Declaration of Generative AI and AI-assisted technologies in the writing process' section before the references.
References Review Articles may include no more than 75 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Review Articles may include up to 6 tables and/or figures. Each illustration must be submitted as a separate file. Review Article figures should preferably be submitted as vector-based .eps, .ai, .ps, .pdf, or .svg files, may be submitted as .pptx, .docx, or .xlsx files, and should not be submitted as .png, .jpeg, .tiff, or .bmp files.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Brief Reports must include an abstract. The abstract must be limited to 250 words. The abstract must be structured. The abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Brief Reports must have a maximum length of 1500 words. The manuscript must be organized under the main headings Introduction, Materials and Methods, Results, and Discussion. Brief Reports must include "Brief Report:" in the title and include three to five keywords, and any use of generative AI in writing must be disclosed in a section titled 'Declaration of Generative AI and AI-assisted technologies in the writing process' before the references.
References Brief Reports may include a maximum of 15 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Brief Reports may include up to 3 tables and/or figures. Each illustration must be submitted as a separate file. Tables must be submitted as editable text rather than images.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Case Reports must include an abstract. Case Report abstracts may be structured or unstructured. Case Report abstracts must include an introduction on the case's uniqueness and contribution, the patient's main concerns and key clinical findings, the primary diagnoses, interventions, and outcomes, and a conclusion with one or more take-away lessons.
Manuscript Case Reports must be 1000 words or less. Case Reports must include Introduction, Case Presentation, Discussion, and a one-paragraph Conclusion sections, and they must include a timeline as a figure or table. Case Reports must include 2 to 5 keywords including "case report," a disclosure statement of conflict of interest, a short Acknowledgement mentioning funding support if applicable, and a statement of patient's informed consent.
References Case Reports may include no more than 5 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order they appear in the text.
Figures & Tables Case Reports may include up to 3 figures and/or tables. Each illustration must be submitted as a separate file. Case Reports must include a timeline presented as a figure or table.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters To The Editor must contain no more than 500 words. Letters To The Editor must be accompanied by a statement of potential sources of conflict of interest.
References Letters To The Editor may include no more than 5 references, including a reference to the article in question. References must be indicated in the text by consecutive superscript arabic numerals and listed in the order in which they appear in the text.
Figures & Tables Figures must be submitted as separate files, and tables must be submitted as editable text rather than images. Figure captions must be supplied separately.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Rapid Communications

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must not exceed 1,000 words excluding references, figures, and tables. Manuscript must be organized into the four main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in the writing process, a 'Declaration of Generative AI and AI-assisted technologies in the writing process' section before the References list.
References Rapid Communications may include no more than 5 references. References must be cited in the text using consecutive superscript Arabic numerals and listed in the reference list in the order of appearance.
Figures & Tables Rapid Communications may include no more than 1 table or figure. Each illustration must be submitted as a separate file. Tables must be submitted as editable text and not as images.
Reformat to Journal of Thoracic Oncology using Livewrite Premium

Recent Publications

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial

Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze, Davit Giorgadze, Konstantin Penkov, Konstantin Laktionov, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Kalinka, Yuntong Li, Debra A.G. McIntyre, Xue Jia, Javier Perez, Manika Kaul, Israel Lowy, Jean-Francois Pouliot, Stefanie Chua, Eric Kim, Frank Seebach, Heather Magnan

10.1016/j.jtho.2026.103980
View Publication

Brief Report: The Prognostic Impact of Common Molecular Alterations in Resected Lung Adenocarcinoma and Implications for the 10th Edition TNM Classification

Huatao Tang, Chaoqiang Deng, Hang Cao, Fangqiu Fu, Molin Zhang, Wangyang Zhu, Yuan Li, Yang Zhang, Haiquan Chen

10.1016/j.jtho.2026.103965
View Publication

IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms

Mary Beth Beasley, Yasushi Yatabe, Mauro Papotti, Wendy A. Cooper, Jules L. Derks, Lynnette Fernandez-Cuesta, Atsuko Kasajima, Sylvie Lantuejoul, Giuseppe Pelosi, Natasha Rekhtman, Anja C. Roden, Ernst Jan M Speel, William D. Travis

10.1016/j.jtho.2026.103977
View Publication

Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project

Sanja Dacic, Daniel Shenker, Mary Redman, Lauren Brunner, Anjali Saqi, Wendy A. Cooper, Alain Borczuk, Jin-Haeng Chung, Carolyn Glass, Javier Martin Lopez, Anja C. Roden, Lynette Sholl, Annikka Weissferdt, Jacqueline Brosnan-Cashman, Stephanie Hennek, Sean Grullon, Juan Posadas, Junya Fujimoto, Casey Connolly, Murry W. Wynes, Beatriz Sanchez -Espiridion, J.Jack Lee, Sabina Berezowska, Teh-Ying Chou, Keith Kerr, Andrew G. Nicholson, Kurt A. Schalper, Ming-Sound Tsao, Neal Ready, Tina Cascone, John Heymach, Boris Sepesi, Catherine Shu, Naiyer Rizvi, Josuha Sonett, Nasser Altorki, Mariano Provencio, Paul A. Bunn, Mark G. Kris, William Travis, Limin Yu, Ignacio Wistuba

10.1016/j.jtho.2026.103953
View Publication

Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with Radiotherapy

Xinyan Xu, Maliazurina B. Saad, Adam Grippin, Hui Xu, Amgad Muneer, Elliana Young, Steven H. Lin, Zhongxing Liao, Saumil Gandhi, Peter Balter, Matthew Stephen Ning, David Qian, Julianna K. Bronk, Aileen Chen, Michael O'Reilly, Quynh-Nhu Nguyen, James Welsh, Julianne M. Pollard-Larkin, John V. Heymach, J. Jack Lee, Jia Wu, Joe Y. Chang

10.1016/j.jtho.2026.103956
View Publication

Frequently asked questions

How long does it take to publish?

4 days from submission to first decision; 5 days from acceptance to online publication

Reformat to Journal of Thoracic Oncology using Livewrite Premium

What are the publication costs?

Open access options are available; CC BY licenses are available only by request for authors whose funding bodies require it.

Reformat to Journal of Thoracic Oncology using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Radiomics and Machine Learning in Medical Imaging Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes RNA modifications and cancer Cancer Diagnosis and Treatment Medical Imaging and Pathology Studies Occupational and environmental lung diseases Neuroendocrine Tumor Research Advances Pleural and Pulmonary Diseases Brain Metastases and Treatment Head and Neck Cancer Studies Multiple and Secondary Primary Cancers Peptidase Inhibition and Analysis Global Cancer Incidence and Screening Medical Imaging Techniques and Applications Metastasis and carcinoma case studies HER2/EGFR in Cancer Research Cancer therapeutics and mechanisms Myasthenia Gravis and Thymoma Esophageal Cancer Research and Treatment

Related Journals

C&
Clinical & Experimental Metastasis Springer Science+Business Media
LC
Lung Cancer Management Future Medicine
OR
Ophthalmology Retina Elsevier BV
IJ
International Journal of Hygiene and Environmental Health Elsevier BV
DA
Drug and Alcohol Dependence Reports Elsevier BV
RP
Recent Patents on Anti-Cancer Drug Discovery Bentham Science Publishers